Cefoperazone Sodium

头孢哌酮钠

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCefoperazone Sodium
Drug Alias Name头孢派酮CefoperazonaCefoperazonum氧哌羟苯唑头Medocef +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1982/11/18
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharmaceutical Group Co Ltd General Pharm Factory
Inactive CompaniesPfizer Inc
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DD12
Related LinksWikipediaDrugBankKEGG